9.98
전일 마감가:
$10.13
열려 있는:
$10.16
하루 거래량:
1.83M
Relative Volume:
1.10
시가총액:
$1.17B
수익:
$260.81M
순이익/손실:
$20.48M
주가수익비율:
76.77
EPS:
0.13
순현금흐름:
$22.67M
1주 성능:
-2.82%
1개월 성능:
-10.41%
6개월 성능:
-28.10%
1년 성능:
-8.10%
다이나백스 테크놀로지스 Stock (DVAX) Company Profile
명칭
Dynavax Technologies Corp
전화
(510) 848-5100
주소
2100 POWELL STREET, EMERYVILLE, CA
DVAX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
DVAX
Dynavax Technologies Corp
|
9.98 | 1.16B | 260.81M | 20.48M | 22.67M | 0.13 |
![]()
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
다이나백스 테크놀로지스 Stock (DVAX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-02-11 | 다운그레이드 | Goldman | Neutral → Sell |
2024-02-01 | 개시 | Goldman | Neutral |
2022-09-27 | 개시 | JMP Securities | Mkt Outperform |
2022-01-06 | 재개 | Goldman | Buy |
2021-08-06 | 개시 | Goldman | Buy |
2020-08-07 | 재확인 | H.C. Wainwright | Buy |
2020-08-03 | 재확인 | H.C. Wainwright | Buy |
2020-06-15 | 개시 | Evercore ISI | Outperform |
2019-10-18 | 개시 | H.C. Wainwright | Buy |
2019-07-11 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2019-02-27 | 재확인 | Cantor Fitzgerald | Overweight |
2018-05-10 | 업그레이드 | JP Morgan | Neutral → Overweight |
2018-03-08 | 재확인 | Cantor Fitzgerald | Overweight |
2018-02-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2017-09-25 | 재확인 | RBC Capital Mkts | Outperform |
2017-09-15 | 개시 | Cantor Fitzgerald | Overweight |
2017-07-31 | 업그레이드 | JP Morgan | Neutral → Overweight |
2017-07-31 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2017-05-09 | 재확인 | RBC Capital Mkts | Sector Perform |
2016-04-28 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2016-04-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2015-11-30 | 개시 | RBC Capital Mkts | Outperform |
2013-11-25 | 업그레이드 | MLV & Co | Hold → Buy |
2013-02-25 | 다운그레이드 | MLV & Co | Buy → Hold |
2012-11-16 | 재확인 | MLV & Co | Buy |
모두보기
다이나백스 테크놀로지스 주식(DVAX)의 최신 뉴스
Applying sector rotation models to Dynavax Technologies CorporationJuly 2025 Market Mood & Real-Time Chart Pattern Alerts - Newser
Top chart patterns to watch in Dynavax Technologies CorporationJuly 2025 Review & Risk Controlled Swing Trade Alerts - Newser
Can machine learning forecast Dynavax Technologies Corporation recoveryMarket Trend Summary & Daily Momentum Trading Reports - Newser
Applying Wyckoff theory to Dynavax Technologies Corporation stockMarket Performance Report & Free Fast Entry Momentum Trade Alerts - Newser
What the charts say about Dynavax Technologies Corporation today2025 Winners & Losers & Real-Time Volume Trigger Notifications - Newser
Multi asset correlation models including Dynavax Technologies CorporationJuly 2025 Intraday Action & Daily Entry Point Alerts - Newser
Intraday pattern recognizer results for Dynavax Technologies CorporationJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
Is Dynavax Technologies Corporation stock entering bullish territoryMarket Weekly Review & Low Volatility Stock Suggestions - Newser
Price action breakdown for Dynavax Technologies CorporationExit Point & AI Driven Stock Movement Reports - Newser
Dynavax Technologies Corporation stock trendline breakdownQuarterly Profit Review & Community Verified Watchlist Alerts - Newser
Visual trend scoring systems applied to Dynavax Technologies CorporationMarket Trend Report & High Return Trade Guides - Newser
Wellington Management Group LLP Has $736,000 Holdings in Dynavax Technologies Corporation $DVAX - Defense World
Northern Trust Corp Cuts Stock Holdings in Dynavax Technologies Corporation $DVAX - Defense World
HighTower Advisors LLC Has $365,000 Position in Dynavax Technologies Corporation $DVAX - Defense World
Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook - Insider Monkey
Dynavax’s SWOT analysis: vaccine maker’s stock poised for growth amid challenges - Investing.com
Visual analytics tools that track Dynavax Technologies Corporation performanceWeekly Trade Summary & Community Consensus Picks - Newser
What recovery options are there for Dynavax Technologies CorporationWeekly Trend Summary & Community Supported Trade Ideas - Newser
Dynavax Technologies Corporation stock volume spike explainedPortfolio Update Report & Long-Term Safe Investment Plans - Newser
Signal strength of Dynavax Technologies Corporation stock in tech scannersPortfolio Value Report & Verified Short-Term Trading Plans - Newser
Using Python tools to backtest Dynavax Technologies Corporation strategiesJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - Newser
When is the best time to exit Dynavax Technologies CorporationJuly 2025 Gainers & Technical Pattern Based Buy Signals - Newser
Will Dynavax Technologies Corporation benefit from macro trendsMarket Trend Review & Free Real-Time Volume Trigger Notifications - Newser
Dynavax Technologies Corporation stock retracement – recovery analysisTrade Analysis Report & Expert-Curated Trade Recommendations - Newser
What data driven models say about Dynavax Technologies Corporation’s futureMarket Sentiment Report & AI Forecast Swing Trade Picks - Newser
Pattern recognition hints at Dynavax Technologies Corporation upsideTrade Signal Summary & Safe Capital Allocation Plans - Newser
What earnings revisions data tells us about Dynavax Technologies CorporationMarket Volume Report & Weekly Chart Analysis and Trade Guides - Newser
Has Dynavax Technologies Corporation formed a bullish divergenceWeekly Gains Summary & Scalable Portfolio Growth Methods - Newser
Analyzing drawdowns of Dynavax Technologies Corporation with statistical toolsRecession Risk & Consistent Growth Stock Picks - Newser
Statistical indicators supporting Dynavax Technologies Corporation’s strength2025 Sector Review & Real-Time Buy Signal Notifications - Newser
다이나백스 테크놀로지스 (DVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
다이나백스 테크놀로지스 주식 (DVAX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Deep Track Biotechnology Maste | 10% Owner |
Aug 21 '25 |
Sale |
11.03 |
1,094,994 |
12,077,784 |
16,696,492 |
Deep Track Biotechnology Maste | 10% Owner |
Aug 22 '25 |
Sale |
10.59 |
970,143 |
10,273,814 |
15,726,349 |
Novack David F | President & COO |
Mar 24 '25 |
Option Exercise |
6.80 |
10,000 |
68,050 |
18,078 |
Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
자본화:
|
볼륨(24시간):